The instrument demonstrated strong internal consistency (Cronbachs = 0.88) in a general-population sample and excellent 2-week testretest reliability ( r = 0.87), with evidence of good validity in both clinical and non-clinical samples [131, 132]
Its technically a dual agonist that activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, producing greater effects than GLP-1-only medications
(PubMed) Rahman L, Voeller D, Rahman M, et al
Some people who have GI side effects on semaglutide tolerate tirzepatide well, and the reverse happens too
During the consultation, you and your provider will review your health history and discuss the treatment, expectations, and side effects in full detail